Table 1.
A summary of the various laboratories and institutes involved in plasma medicine research, predominantly the application of plasma plume technologies for topical (e.g., dermal) applications, and/or to perform in vitro cell assay experiments
University / Institute | Application | Ref. |
---|---|---|
Ajou University | Cancer (in vitro) | 24–30 |
Changchun University of Science and Technology | Cancer (in vitro) | 31 |
Clemson University | Melanoma (in vitro) | 32 |
Conway Institute of Biomolecular and Biomedical Research | Cancer (in vitro) | 33 |
CSIRO | Cancer (in vitro) | 34,35 |
Drexel University | Dermal applications; disinfection; melanoma (in vivo); cancer (in vitro) | 36–48 |
Dong-A University | Cancer (in vitro) | 49–52 |
Eindhoven University of Technology | Disinfection, cancer (in vitro) | %53 |
George Washington University | Fibroblast modification; wound healing; cancer (in vitro); electrosurgery | %54–%67 |
Heinrich-Heine University | Skin infection, wound healing | %68 |
Kanazawa University | Wound healing | %69 |
Korea Advanced Institute of Science and Technology | Cancer (in vitro) | %70 |
Kwangwoon University Plasma Bioscience Research Center | Cancer (in vitro) | %71–%73 |
Leibniz Institute for Plasma Science and Technology | Dermal applications; cancer (in vitro) | %74–%88 |
Max Planck Institute | Dermal applications; cancer (in vitro) | %89–%91 |
McGill University | Cancer (in vitro) | %92,%93 |
Nagoya University | Cancer (in vitro); anti-fungal; macular degeneration | %94–%104 |
National Institute for Laser, Plasma, and Radiation Physics | Cancer (in vitro) | %105 |
Old Dominion University | Fungal decontamination, cancer (in vitro) | %106,%107 |
Plasma Engineering Research Lab, Texas A&M | Surface decontamination, antibiotic-resistant bacteria, wound treatment, cancer (in vitro) | %108–%117 |
Pohang University | Melanoma | %118,%119 |
Pusan National University | Melanoma | %120 |
Queen's University Belfast Centre for Plasma Physics | Nosocomial infection prevention, biofilm eradication, cancer (in vitro) | %121–%128 |
Shahid Beheshti University | Melanoma | %129 |
Umversite' d'Orleans | Subcutaneous tumor treatement (murine model) | %130–%134 |
University of Buffalo | Melanoma | %135,%136 |
University of Campinas | Fibroblast modification | %137 |
University of Iasi | Dermal applications | %138 |
University of Notre Dame | Cancer (in vitro) | %139 |
York Plasma Institute, University of York | Cancer (in vitro) | %140 |